from Reuters: Health News https://reut.rs/2GlUjt2
Roche moves to broaden Kadcyla use in biosimilar defense
Roche aims to broaden use of its Kadcyla breast cancer drug as the Swiss pharmaceuticals giant defends itself against rivals who are crowding in with cheaper biosimilar copies of its older, patent-expired mainstay Herceptin.
from Reuters: Health News https://reut.rs/2GlUjt2
from Reuters: Health News https://reut.rs/2GlUjt2
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment